Romain Micol

Romain Micol is President and CEO of Combined Therapeutics. Romain has over fifteen years of experience in the biotechnology and pharmaceutical industries. Prior to joining Combined Therapeutics, they were Director of Business Development at Transgene. From 2008 to 2010, they were a Medical Advisor at the Institut Mérieux, where they oversaw clinical trials and developed marketing strategies. Romain also served as a Physician at the Assistance Publique Hopitaux de Paris and the Institut Pasteur. Romain has been a Principal Investigator on several research projects.

Romain Micol has an MD from Pierre and Marie Curie University, a PhD from Université Paris Cité, and an MBA from Hult International Business School. Romain also has an LLM from The London School of Economics and Political Science (LSE) and an Advanced Management Program from the MIT Sloan School of Management. Additionally, they have an ADVAC from the University of Geneva and an MD in Public Health from Pierre and Marie Curie University. Finally, they have a MPH in Epidemiology and biostatistics from Université de Bordeaux and a Master in Health economy and management from Université Paris Dauphine - PSL.

Some individuals on their team include Teddy Jégu - Project Manager, Pierre Vochel - Senior Manager Strategy & Finance, and Kim Foster - Research Associate.